Therapy and drug resistance in Helicobacter pylori infection
- 1 December 2000
- journal article
- Published by Elsevier in Digestive and Liver Disease
- Vol. 32, 207-210
- https://doi.org/10.1016/s1590-8658(00)80280-7
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- The impact of antibiotic resistance on the efficacy of three 7‐day regimens against Helicobacter pyloriAlimentary Pharmacology & Therapeutics, 2000
- H. pylori antimicrobial resistance in the united states: Preliminary results of a 9-center studyGastroenterology, 2000
- Evaluation of risk factors in the surveillance of heucobacter pywri antimicrobial resistance partnership (SHARP) in the united states from 1993–1999Gastroenterology, 2000
- Triple therapy in the eradication of Helicobacter pylori in patients with duodenal ulcer disease: results of a multicentre study in South‐East AsiaAlimentary Pharmacology & Therapeutics, 2000
- Antimicrobial Susceptibility Testing of Helicobacter pylori in a Large Multicenter Trial: the MACH 2 StudyAntimicrobial Agents and Chemotherapy, 1999
- A systematic review of Helicobacter pylori eradication therapy—the impact of antimicrobial resistance on eradication ratesAlimentary Pharmacology & Therapeutics, 1999
- Subpopulations of Helicobacter pylori Are Responsible for Discrepancies in the Outcome of Nitroimidazole Susceptibility TestingAntimicrobial Agents and Chemotherapy, 1999
- Amoxycillin tolerance in Helicobacter pylori.Journal of Antimicrobial Chemotherapy, 1999
- Epidemiology and mechanism of antibiotic resistance inGastroenterology, 1998
- Antibiotic resistance in : Implications for therapyGastroenterology, 1998